Broad Institute, Cambridge, Massachusetts 02142, USA.
Genes Dev. 2012 Sep 15;26(18):2075-87. doi: 10.1101/gad.197020.112. Epub 2012 Aug 28.
Genome-wide association studies (GWASs) have identified a genetic variant of moderate effect size at 6p21.1 associated with erythrocyte traits in humans. We show that this variant affects an erythroid-specific enhancer of CCND3. A Ccnd3 knockout mouse phenocopies these erythroid phenotypes, with a dramatic increase in erythrocyte size and a concomitant decrease in erythrocyte number. By examining human and mouse primary erythroid cells, we demonstrate that the CCND3 gene product cyclin D3 regulates the number of cell divisions that erythroid precursors undergo during terminal differentiation, thereby controlling erythrocyte size and number. We illustrate how cell type-specific specialization can occur for general cell cycle components-a finding resulting from the biological follow-up of unbiased human genetic studies.
全基因组关联研究(GWAS)已经在人类中鉴定出与红细胞特征相关的位于 6p21.1 的遗传变异,其效应中等。我们表明,该变异影响 CCND3 的一个红系特异性增强子。Ccnd3 敲除小鼠模拟了这些红细胞表型,红细胞体积显著增加,红细胞数量相应减少。通过检查人类和小鼠的原代红细胞,我们证明 CCND3 基因产物细胞周期蛋白 D3 调节红细胞前体细胞在终末分化过程中经历的细胞分裂次数,从而控制红细胞的大小和数量。我们说明了一般细胞周期成分如何发生细胞类型特异性特化——这一发现源于对无偏人类遗传研究的生物学后续研究。